Texas Attorney General Sues Tylenol Makers Regarding Autism Spectrum Claims

Courtroom Case
Ken Paxton, who supports former President Trump who is running for US Senate, claimed the drug companies of withholding the risks of Tylenol

The top legal official in Texas Ken Paxton is taking legal action against the producers of Tylenol, claiming the companies concealed safety concerns that the drug posed to children's brain development.

The lawsuit comes four weeks after President Donald Trump promoted an unproven link between taking acetaminophen - referred to as paracetamol - while pregnant and autism spectrum disorder in offspring.

Paxton is taking legal action against Johnson & Johnson, which formerly manufactured the medication, the sole analgesic recommended for pregnant women, and Kenvue, which presently makes it.

In a official comment, he claimed they "misled consumers by profiting off of discomfort and pushing pills without regard for the dangers."

The manufacturer states there is insufficient reliable data connecting Tylenol to autism.

"These companies misled for generations, knowingly endangering millions to increase profits," Paxton, a Republican, declared.

Kenvue commented that it was "seriously troubled by the spread of false claims on the safety of acetaminophen and the possible consequences that could have on the well-being of US mothers and children."

On its online platform, the company also said it had "regularly reviewed the pertinent research and there is lacking reliable evidence that shows a proven link between using paracetamol and autism."

Organizations acting on behalf of medical professionals and medical practitioners agree.

The leading OB-GYN organization has said acetaminophen - the primary component in Tylenol - is a restricted selection for women during pregnancy to address discomfort and elevated temperature, which can present major wellness concerns if left untreated.

"In multiple decades of research on the use of acetaminophen in gestation, not a single reputable study has conclusively proven that the use of acetaminophen in any stage of pregnancy causes brain development issues in young ones," the association stated.

The lawsuit mentions current declarations from the Trump administration in claiming the medication is reportedly hazardous.

Recently, Trump generated worry from health experts when he instructed women during pregnancy to "resist strongly" not to take Tylenol when sick.

The US Food and Drug Administration then published an announcement that medical professionals should think about restricting the use of acetaminophen, while also mentioning that "a direct connection" between the medication and autism in minors has remains unverified.

Health Secretary RFK Jr, who manages the FDA, had pledged in April to initiate "extensive scientific investigation" that would establish the source of autism in a short period.

But experts advised that finding a single cause of autism spectrum disorder - thought by researchers to be the outcome of a intricate combination of genetic and external influences - would not be simple.

Autism is a category of permanent neurological difference and condition that affects how people experience and engage with the environment, and is identified using medical professional evaluations.

In his legal document, the attorney general - aligned with the former president who is running for the Senate - alleges Kenvue and Johnson & Johnson "deliberately disregarded and tried to quiet the evidence" around paracetamol and autism spectrum disorder.

The lawsuit seeks to make the corporations "destroy any promotional materials" that states Tylenol is secure for pregnant women.

This legal action parallels the grievances of a group of parents of young ones with autism spectrum disorder and ADHD who filed suit against the makers of acetaminophen in recently.

Judicial authorities rejected the case, saying research from the plaintiffs' authorities was not conclusive.

Grace Pope
Grace Pope

A passionate gamer and tech enthusiast with years of experience in game journalism and community engagement.